NUS - Nu Skin Enterprises Inc Stock Price, Fair Value and News

13.65USD-0.21 (-1.52%)Market Closed

Market Summary

USD13.65-0.21

Market Closed

-1.52%

NUS Alerts

Big fall in Revenue (Y/Y)

Big fall in earnings (Y/Y)
Losses in recent quarter

NUS Stock Price

View Fullscreen

NUS RSI Chart

NUS Valuation

Market Cap

678.0M

Price/Earnings (Trailing)

-204.57

Price/Sales (Trailing)

0.36

EV/EBITDA

10.75

Price/Free Cashflow

NUS Price/Sales (Trailing)

NUS Profitability

EBT Margin

0.69%

Return on Equity

-0.41%

Return on Assets

-0.19%

Free Cashflow Yield

12.5%

NUS Fundamentals

NUS Revenue

Revenue (TTM)

1.9B

Rev. Growth (Yr)

-13.33%

Rev. Growth (Qtr)

-14.6%

NUS Earnings

Earnings (TTM)

-3.3M

Earnings Growth (Yr)

-104.69%

Earnings Growth (Qtr)

-107.32%

Breaking Down NUS Revenue

Last 7 days

3.3%

Last 30 days

10.4%

Last 90 days

-0.3%

Trailing 12 Months

-62.5%

How does NUS drawdown profile look like?

NUS Financial Health

Current Ratio

2.09

Debt/Equity

0.56

Debt/Cashflow

0.32

NUS Investor Care

Buy Backs (1Y)

0.48%

Diluted EPS (TTM)

-0.07

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	1.9B	0	0	0
2023	2.1B	2.0B	2.0B	2.0B
2022	2.6B	2.5B	2.4B	2.2B
2021	2.7B	2.8B	2.8B	2.7B
2020	2.3B	2.3B	2.4B	2.6B
2019	2.7B	2.6B	2.5B	2.4B
2018	2.4B	2.6B	2.7B	2.7B
2017	2.2B	2.2B	2.1B	2.3B
2016	2.2B	2.2B	2.2B	2.2B
2015	2.4B	2.4B	2.3B	2.2B
2014	3.3B	3.3B	3.0B	2.6B
2013	2.2B	2.3B	2.7B	3.2B
2012	1.8B	2.0B	2.0B	2.1B
2011	1.6B	1.6B	1.6B	1.7B
2010	0	1.4B	1.5B	1.5B
2009	0	1.3B	1.3B	1.3B
2008	0	0	0	1.2B

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Nu Skin Enterprises Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 02, 2024	woodbury edwina d	sold	-20,349	12.02	-1,693	-
Apr 25, 2024	lipman andrew d	sold	-24,680	12.34	-2,000	-
Mar 25, 2024	lipman andrew d	sold	-24,640	12.32	-2,000	-
Mar 11, 2024	battle emma s.	acquired	222	13.1	17.00	-
Mar 06, 2024	woodbury edwina d	acquired	102	12.82	8.00	-
Feb 27, 2024	napierski ryan s	acquired	-	-	189,574	president and ceo
Feb 27, 2024	hatchett steven keith	acquired	-	-	39,495	chief product officer
Feb 27, 2024	thomas james d	acquired	-	-	43,444	chief financial officer
Feb 27, 2024	clark chayce david	acquired	-	-	69,116	evp and general counsel
Feb 26, 2024	lipman andrew d	sold	-24,920	12.46	-2,000	-

Which funds bought or sold NUS recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	COMERICA BANK	reduced	-17.73	-207,359	293,348	-%
May 16, 2024	JANE STREET GROUP, LLC	added	113	677,324	1,977,940	-%
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-6.22	-340,156	683,880	-%
May 15, 2024	Point72 Europe (London) LLP	sold off	-100	-176,042	-	-%
May 15, 2024	Walleye Capital LLC	added	95.25	952,082	3,390,440	0.01%
May 15, 2024	Robertson Opportunity Capital, LLC	unchanged	-	-446,144	1,103,790	0.50%
May 15, 2024	Squarepoint Ops LLC	sold off	-100	-810,571	-	-%
May 15, 2024	Engineers Gate Manager LP	reduced	-4.98	-905,516	1,894,940	0.05%
May 15, 2024	PDT Partners, LLC	sold off	-100	-450,738	-	-%
May 15, 2024	Petrus Trust Company, LTA	added	113	192,065	562,521	0.05%

Are Funds Buying or Selling NUS?

Are funds buying NUS calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NUS

No. of Funds

Unveiling Nu Skin Enterprises Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	vanguard group inc	12.58%	6,215,151	SC 13G/A
Feb 09, 2024	invesco ltd.	5.8%	2,856,897	SC 13G
Feb 08, 2024	wellington management group llp	0.00%	0	SC 13G/A
Jan 25, 2024	state street corp	5.81%	2,871,749	SC 13G/A
Jan 22, 2024	blackrock inc.	17.2%	8,508,678	SC 13G/A
Aug 09, 2023	state street corp	6.11%	3,051,276	SC 13G/A
Feb 13, 2023	renaissance technologies llc	4.63%	2,287,596	SC 13G/A
Feb 09, 2023	vanguard group inc	13.13%	6,490,840	SC 13G/A
Feb 09, 2023	state street corp	14.94%	7,384,649	SC 13G/A
Feb 06, 2023	wellington management group llp	7.15%	3,535,969	SC 13G/A

Recent SEC filings of Nu Skin Enterprises Inc

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 08, 2024	8-K	Current Report
May 03, 2024	4	Insider Trading
May 02, 2024	144	Notice of Insider Sale Intent
Apr 25, 2024	4	Insider Trading
Apr 12, 2024	ARS	ARS
Apr 12, 2024	DEF 14A	DEF 14A
Apr 12, 2024	DEFA14A	DEFA14A
Apr 01, 2024	4	Insider Trading
Mar 25, 2024	144	Notice of Insider Sale Intent

Peers (Alternatives to Nu Skin Enterprises Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
PG	395.7B	84.1B	6.80%	9.91%	26.16	4.71	3.82%	5.63%
CL	77.2B	19.8B	8.50%	18.11%	29.57	3.91	7.71%	63.39%
EL	48.4B	15.3B	-2.44%	-32.61%	72.94	3.15	-3.25%	-39.29%
CHD	26.0B	5.9B	2.80%	12.53%	33.35	4.38	8.05%	89.02%
CLX	16.8B	7.2B	-4.70%	-18.34%	70.19	2.34	0.53%	224.32%
COTY	9.2B	6.1B	0.19%	-6.00%	42.16	1.51	13.69%	13.11%
ELF	8.8B	890.1M	-4.70%	74.87%	67.98	9.88	79.24%	176.22%
MID-CAP
IPAR	4.0B	1.3B	0.70%	-6.53%	28.55	3	15.88%	-0.05%
NWL	3.4B	8.0B	17.03%	-8.34%	-11.41	0.42	-10.08%	-121.80%
HIMS	3.1B	959.4M	17.49%	41.97%	-1.3K	3.24	55.65%	96.05%
HELE	2.6B	2.0B	13.24%	10.40%	15.38	1.29	-3.26%	17.67%
SMALL-CAP
EPC	2.0B	2.3B	14.38%	-6.83%	16.18	0.88	1.98%	28.45%
ACU	144.4M	190.6M	-7.81%	61.36%	7.83	0.76	-2.98%	477.15%
GROV	55.5M	241.3M	0.66%	232.61%	-1.65	0.23	-20.28%	37.16%
UG	42.3M	11.6M	17.05%	-1.29%	15.37	3.65	1.70%	13.94%

Nu Skin Enterprises Inc News

Latest updates

Nu Skin Enterprises Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Income Statement (Quarterly)																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-14.6%	417	489	499	500	481	522	538	561	605	673	641	704	677	748	703	612	518	583	590	624	624
Gross Profit	-16.6%	294	352	292	365	348	375	364	413	443	500	482	532	506	553	520	458	392	443	450	469	477
Operating Expenses	-15.2%	285	336	319	322	332	347	385	361	391	479	417	447	444	465	446	400	356	388	380	395	408
S&GA Expenses	-15.3%	154	181	188	185	188	201	216	219	243	263	260	281	276	295	281	249	206	228	232	246	250
EBITDA Margin	-9.4%	0.04*	0.05*	0.06*	0.06*	0.06*	0.07*	0.07*	0.10*	0.11*	0.11*	0.14*	0.14*	-	-	-	-	-	-	-	-	-
Income Taxes	-20.4%	2.00	2.00	3.00	10.00	3.00	-32.86	-3.60	9.00	12.00	28.00	18.00	22.00	17.00	18.00	18.00	18.00	11.00	13.00	21.00	25.00	23.00
Earnings Before Taxes	-88.2%	1.00	9.00	-34.45	37.00	15.00	24.00	-28.96	43.00	51.00	18.00	68.00	81.00	64.00	91.00	75.00	60.00	30.00	54.00	65.00	71.00	66.00
EBT Margin	-49.1%	0.01*	0.01*	0.02*	0.02*	0.03*	0.04*	0.03*	0.07*	0.08*	0.09*	0.11*	0.11*	-	-	-	-	-	-	-	-	-
Net Income	-107.3%	-0.53	7.00	-36.95	27.00	11.00	57.00	-25.39	34.00	39.00	-9.23	50.00	59.00	47.00	73.00	56.00	42.00	20.00	40.00	44.00	46.00	43.00
Net Income Margin	-139.9%	0.00*	0.00*	0.03*	0.03*	0.04*	0.05*	0.02*	0.05*	0.05*	0.05*	0.08*	0.08*	-	-	-	-	-	-	-	-	-
Free Cashflow	-126.5%	-8.96	34.00	39.00	21.00	-33.56	12.00	3.00	37.00	-2.74	91.00	17.00	3.00	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-3.6%	1,742	1,806	1,793	1,894	1,825	1,821	1,763	1,901	1,892	1,906	1,974	2,050	1,950	1,957	1,817	1,794	1,746	1,769	1,737	1,791	1,755
Current Assets	-7.8%	647	702	701	793	774	760	778	883	849	873	891	962	901	903	772	786	730	740	739	788	748
Cash Equivalents	-17.0%	213	256	233	236	230	265	294	364	302	340	282	355	339	403	367	376	353	336	320	361	310
Inventory	-5.3%	265	280	291	372	367	346	327	354	382	400	415	391	363	314	270	262	257	276	283	293	304
Net PPE	-2.3%	423	433	429	430	438	445	433	443	449	454	464	474	464	468	456	445	449	454	448	443	446
Goodwill	0%	231	231	229	20.00	206	206	206	206	206	206	216	216	203	203	197	197	197	197	197	197	197
Liabilities	-5.4%	932	984	971	998	932	924	921	960	958	994	1,038	1,132	1,079	1,063	989	1,002	946	894	891	956	944
Current Liabilities	-5.9%	309	329	434	445	373	359	366	384	494	530	541	616	562	543	466	485	420	357	368	415	402
Long Term Debt	-5.2%	453	478	363	368	373	377	382	387	259	269	279	288	298	305	313	320	327	334	342	349	356
LT Debt, Current	20.0%	30.00	25.00	140	140	48.00	25.00	43.00	40.00	110	108	110	153	90.00	30.00	30.00	95.00	95.00	28.00	25.00	60.00	45.00
LT Debt, Non Current	-100.0%	-	478	363	368	373	377	382	387	259	269	279	288	298	305	313	320	327	334	342	349	356
Shareholder's Equity	-1.4%	810	822	822	895	893	897	842	941	934	913	936	918	871	894	827	792	800	875	846	835	811
Retained Earnings	-0.2%	1,867	1,870	1,882	1,939	1,931	1,939	1,901	1,946	1,931	1,912	1,940	1,909	1,869	1,841	1,786	1,749	1,727	1,728	1,708	1,685	1,659
Additional Paid-In Capital	-0.5%	619	622	619	616	611	613	610	606	599	602	591	587	579	580	570	563	558	558	557	556	553
Shares Outstanding	-0.3%	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	50.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	1,640	-	-	-	2,170	-	-	-	2,800	-	-	-	1,940	-	-	-	2,700	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-93.9%	3,318	54,167	51,027	35,522	-22,077	25,525	28,441	46,555	7,541	109,509	30,214	20,715	-18,856	94,693	118,367	97,054	69,027	49,903	53,551	82,663	-8,186
Share Based Compensation	36.0%	4,242	3,118	3,725	4,801	4,002	3,047	3,171	2,022	4,127	6,718	3,093	6,580	6,803	8,621	7,115	4,869	3,455	260	1,015	3,593	5,041
Cashflow From Investing	39.8%	-9,262	-15,398	-11,906	-92,501	-14,696	-13,385	-25,211	-18,350	-10,133	-15,577	-17,914	-36,439	-18,796	-29,489	-21,450	-9,305	-19,184	-13,283	-23,683	-16,304	-18,142
Cashflow From Financing	-57.7%	-31,955	-20,265	-38,374	67,989	1,380	-50,794	-61,109	46,158	-33,759	-35,916	-80,019	29,388	-18,155	-41,839	-110,794	-69,554	-22,979	-25,552	-62,570	-13,705	-52,967
Dividend Payments	-84.5%	2,979	19,269	19,486	19,475	19,392	19,027	19,303	19,392	19,293	18,936	19,007	19,040	19,289	19,100	19,245	19,356	20,686	20,553	20,552	20,553	20,531
Buy Backs	-	-	-	13,011	-	-	10,007	40,028	10,004	10,006	10,005	10,005	10,004	50,406	16,973	19,994	46,481	60,886	-	-	-	825

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NUS Income Statement

2024-03-31

Consolidated Statements of Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Consolidated Statements of Income [Abstract]
Revenue	$ 417,306	$ 481,462
Cost of sales	123,242	133,588
Gross profit	294,064	347,874
Operating expenses:
Selling expenses	153,542	188,124
General and administrative expenses	124,566	133,899
Restructuring and impairment expenses	7,134	9,787
Total operating expenses	285,242	331,810
Operating income	8,822	16,064
Interest expense	7,325	4,888
Other income (expense), net	(396)	3,412
Income before provision for income taxes	1,101	14,588
Provision for income taxes	1,634	3,212
Net (loss) income	$ (533)	$ 11,376
Net (loss) income per share (Note 6):
Basic (in dollars per share)	$ (0.01)	$ 0.23
Diluted (in dollars per share)	$ (0.01)	$ 0.23
Weighted-average common shares outstanding:
Basic (in shares)	49,538	49,644
Diluted (in shares)	49,538	50,058

NUS Balance Sheet

2024-03-31

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 212,532	$ 256,057
Current investments	8,674	11,759
Accounts receivable, net	67,041	72,879
Inventories, net	265,100	279,978
Prepaid expenses and other	93,913	81,198
Total current assets	647,260	701,871
Property and equipment, net	422,818	432,965
Operating lease right-of-use assets	93,092	90,107
Goodwill	230,768	230,768
Other intangible assets, net	101,933	105,309
Other assets	246,044	245,443
Total assets	1,741,915	1,806,463
Current liabilities:
Accounts payable	32,237	43,505
Accrued expenses	247,068	260,366
Current portion of long-term debt	30,000	25,000
Total current liabilities	309,305	328,871
Operating lease liabilities	74,198	70,943
Long-term debt	453,183	478,040
Other liabilities	95,023	106,641
Total liabilities	931,709	984,495
Commitments and contingencies (Notes 5 and 11)
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued	91	91
Additional paid-in capital	618,706	621,853
Treasury stock, at cost - 40.9 million and 41.1 million shares	(1,564,942)	(1,570,440)
Accumulated other comprehensive loss	(110,607)	(100,006)
Retained earnings	1,866,958	1,870,470
Total stockholders' equity	810,206	821,968
Total liabilities and stockholders' equity	$ 1,741,915	$ 1,806,463

About Nu Skin Enterprises Inc

Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.

CEO	Mr. Ryan S. Napierski
WEBSITE	nuskin.com
INDUSTRY	Household Products
EMPLOYEES	3800

Nu Skin Enterprises Inc Frequently Asked Questions

What is the ticker symbol for Nu Skin Enterprises Inc? What does NUS stand for in stocks?

NUS is the stock ticker symbol of Nu Skin Enterprises Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nu Skin Enterprises Inc (NUS)?

As of Fri May 17 2024, market cap of Nu Skin Enterprises Inc is 677.96 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers.

What is the fair value of NUS stock?

You can check NUS's fair value in chart for subscribers. The fair value of Nu Skin Enterprises Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nu Skin Enterprises Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUS so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nu Skin Enterprises Inc a good stock to buy?

The fair value guage provides a quick view whether NUS is over valued or under valued. Whether Nu Skin Enterprises Inc is cheap or expensive depends on the assumptions which impact Nu Skin Enterprises Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUS.

What is Nu Skin Enterprises Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NUS's PE ratio (Price to Earnings) is -204.57 and Price to Sales (PS) ratio is 0.36. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUS PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nu Skin Enterprises Inc's stock?

In the past 10 years, Nu Skin Enterprises Inc has provided -0.133 (multiply by 100 for percentage) rate of return.